Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.
about
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for preventionAlcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a systematic review and meta-analysisComparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus.HIV infection, viral hepatitis and liver fibrosis among prison inmates in West AfricaA pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections.Point-of-care testing for sexually transmitted infections: recent advances and implications for disease controlPerformance evaluation of the OraQuick hepatitis C virus rapid antibody testThe new paradigm of hepatitis C therapy: integration of oral therapies into best practices.Rapid diagnostic HCV antibody assays.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Is rapid hepatitis C virus testing from corpses a screening option for index persons who have died after mass-casualty incidents in high-prevalence settings in the field?Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infection.Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature.Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.
P2860
Q26801456-71FE6983-8638-4678-A63B-D62BC8B78009Q33787607-01431A15-D8C7-47ED-BADF-F5C15440640DQ35224772-AC353594-36D9-41B1-B385-576C292259C9Q35935659-B12E985A-4FAB-429F-88CF-93CE5CB5D104Q36042246-EE33BE0E-715C-4A5A-9EAB-BE19C32871F1Q36571408-381C24CA-F12D-475B-9E8F-092861A16108Q36792243-2037DEBB-B1DC-4BB4-83C6-814CD2F62169Q36821811-ABF39E00-CE87-413E-A2EA-B6020C1F87E9Q37455611-0F753E6E-72E4-4629-93A1-F2718FD9A8CBQ38074389-C2B34FFC-8E77-4008-94CA-9910CA9F9234Q38613271-D10EE42D-A250-47E2-88C9-EB77830763F7Q38661825-DF9AA45E-708D-44BC-81CD-962EC176F4B2Q39041105-887DFC21-3D9E-4CDA-A28D-04DC8A0810D4Q44626456-37ABEA19-5EFC-4CD6-B44E-87933A05AB66Q45191773-48F208FB-1407-4C7F-B90A-0A87E94A2D39Q47594606-262D52A7-5082-442A-B685-94369FA200D0
P2860
Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Field-based performance of thr ...... inject drugs in San Diego, CA.
@ast
Field-based performance of thr ...... inject drugs in San Diego, CA.
@en
type
label
Field-based performance of thr ...... inject drugs in San Diego, CA.
@ast
Field-based performance of thr ...... inject drugs in San Diego, CA.
@en
prefLabel
Field-based performance of thr ...... inject drugs in San Diego, CA.
@ast
Field-based performance of thr ...... inject drugs in San Diego, CA.
@en
P2093
P2860
P1476
Field-based performance of thr ...... inject drugs in San Diego, CA.
@en
P2093
C M Weinbaum
E H Teshale
J Cuevas-Mota
R S Garfein
P2860
P304
P356
10.1016/J.JCV.2012.04.003
P577
2012-05-03T00:00:00Z